Vitrolife Investor Relations Material
Latest events
Q2 2025
Vitrolife
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vitrolife Group
Access all reports
Vitrolife AB develops and markets products for assisted reproduction. It offers fertility products, such as media, cultureware, and various disposable products; cryopreservation kits and equipment; labware, including pipettes and CO2 incubators; ICSI catheters and micromanipulation products; and diagnostic products, gynecological instruments, and basic equipment and consumables. The company sells its products directly to end users or through distributors in approximately 90 countries worldwide. Vitrolife AB was founded in 1994 and is headquartered in Gothenburg, Sweden.
Key slides for Vitrolife Group
Q2 2025
Vitrolife Group
Q2 2025
Vitrolife Group
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
VITR
Country
🇸🇪 Sweden